SourceOne Stock Info  Your one source site for stock research

 

 

 

Company Website

Investor Relations

 

 

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

 

 

 

 

 

 

 

 

Amylin Pharmaceuticals, Inc.

 

AMLN

Amylin Pharmaceuticals is a biopharmaceutical company engaged in the research, development and commercialization of drug candidates for the treatment of diabetes, obesity and cardiovascular disease. Amylin has two lead drug candidates in late stage development for the treatment of diabetes, SYMLIN (pramlintide acetate) and exenatide. Its drug candidates for the potential treatment of obesity are AC137 and AC162352. Drug candidates for the treatment of cardiovascular disease are AC2592 (glucagon-like peptide (GLP-1)), and AC3056.

 

Stock Quotes and Other Information

Nasdaq

NYSE

Msn

Yahoo

Silicon Investor

Excite

Lycos

Market Watch

Clear Station

StockHouse

 

SourceOne Message Board

 

Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35

 

Home